These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


279 related items for PubMed ID: 23380292

  • 1. A randomized, double-blind, placebo-controlled trial of a highly purified equine F(ab)2 antibody black widow spider antivenom.
    Dart RC, Bogdan G, Heard K, Bucher Bartelson B, Garcia-Ubbelohde W, Bush S, Arnold T, Clark RC, Hendey GW, Holstege C, Spradley EA.
    Ann Emerg Med; 2013 Apr; 61(4):458-67. PubMed ID: 23380292
    [Abstract] [Full Text] [Related]

  • 2. The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')2 Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
    Dart RC, Bush SP, Heard K, Arnold TC, Sutter M, Campagne D, Holstege CP, Seifert SA, Lo JCY, Quan D, Borron S, Meurer DA, Burnham RI, McNally J, Garcia-Ubbelohde W, Anderson VE.
    Ann Emerg Med; 2019 Sep; 74(3):439-449. PubMed ID: 30926190
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom Evaluation (RAVE-II) study.
    Isbister GK, Page CB, Buckley NA, Fatovich DM, Pascu O, MacDonald SP, Calver LA, Brown SG, RAVE Investigators.
    Ann Emerg Med; 2014 Dec; 64(6):620-8.e2. PubMed ID: 24999282
    [Abstract] [Full Text] [Related]

  • 4. Anaphylaxis to black widow spider antivenom.
    Hoyte CO, Cushing TA, Heard KJ.
    Am J Emerg Med; 2012 Jun; 30(5):836.e1-2. PubMed ID: 21641165
    [Abstract] [Full Text] [Related]

  • 5. Examination of adverse events following black widow antivenom use in California.
    Nordt SP, Clark RF, Lee A, Berk K, Lee Cantrell F.
    Clin Toxicol (Phila); 2012 Jan; 50(1):70-3. PubMed ID: 22175789
    [Abstract] [Full Text] [Related]

  • 6. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
    Gerardo CJ, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Ryan S, Gasior M, Anderson VE, Lavonas EJ.
    Ann Emerg Med; 2017 Aug; 70(2):233-244.e3. PubMed ID: 28601268
    [Abstract] [Full Text] [Related]

  • 7. A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism--the RAVE study.
    Isbister GK, Brown SG, Miller M, Tankel A, Macdonald E, Stokes B, Ellis R, Nagree Y, Wilkes GJ, James R, Short A, Holdgate A.
    QJM; 2008 Jul; 101(7):557-65. PubMed ID: 18400776
    [Abstract] [Full Text] [Related]

  • 8. Priapism after western black widow spider (Latrodectus hesperus) envenomation.
    Bush S, McCune R, Phan T.
    Wilderness Environ Med; 2014 Mar; 25(1):80-1. PubMed ID: 24412661
    [Abstract] [Full Text] [Related]

  • 9. Black and brown widow spider bites in South Africa. A series of 45 cases.
    Müller GJ.
    S Afr Med J; 1993 Jun; 83(6):399-405. PubMed ID: 8211456
    [Abstract] [Full Text] [Related]

  • 10. [Neurotoxic manifestations of black widow spider envenomation in paediatric patients].
    Sotelo-Cruz N, Gómez-Rivera N.
    Neurologia; 2016 May; 31(4):215-22. PubMed ID: 26304660
    [Abstract] [Full Text] [Related]

  • 11. Treatment of pediatric black widow spider envenomation: A national poison center's experience.
    Glatstein M, Carbell G, Scolnik D, Rimon A, Hoyte C.
    Am J Emerg Med; 2018 Jun; 36(6):998-1002. PubMed ID: 29133072
    [Abstract] [Full Text] [Related]

  • 12. Latrodectism: a prospective cohort study of bites by formally identified redback spiders.
    Isbister GK, Gray MR.
    Med J Aust; 2003 Jul 21; 179(2):88-91. PubMed ID: 12864719
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled trial of antivenom for local effects of green pit viper bites.
    Rojnuckarin P, Chanthawibun W, Noiphrom J, Pakmanee N, Intragumtornchai T.
    Trans R Soc Trop Med Hyg; 2006 Sep 21; 100(9):879-84. PubMed ID: 16466758
    [Abstract] [Full Text] [Related]

  • 14. Black widow spider (Latrodectus mactans) antivenom in clinical practice.
    Monte AA.
    Curr Pharm Biotechnol; 2012 Aug 21; 13(10):1935-9. PubMed ID: 22352727
    [Abstract] [Full Text] [Related]

  • 15. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
    Boyer LV, Chase PB, Degan JA, Figge G, Buelna-Romero A, Luchetti C, Alagón A.
    Toxicon; 2013 Nov 21; 74():101-8. PubMed ID: 23948058
    [Abstract] [Full Text] [Related]

  • 16. Red-back spider (Latrodectus hasselti) antivenom prevents the toxicity of widow spider venoms.
    Graudins A, Padula M, Broady K, Nicholson GM.
    Ann Emerg Med; 2001 Feb 21; 37(2):154-60. PubMed ID: 11174232
    [Abstract] [Full Text] [Related]

  • 17. The use of visual analog pain scales in black widow spider envenomation.
    Rogers JJ, Stanford C, Dart RC.
    J Med Toxicol; 2006 Mar 21; 2(1):46-7. PubMed ID: 18072112
    [No Abstract] [Full Text] [Related]

  • 18. A US perspective of symptomatic Latrodectus spp. envenomation and treatment: a National Poison Data System review.
    Monte AA, Bucher-Bartelson B, Heard KJ.
    Ann Pharmacother; 2011 Dec 21; 45(12):1491-8. PubMed ID: 22116992
    [Abstract] [Full Text] [Related]

  • 19. Antivenom for critically ill children with neurotoxicity from scorpion stings.
    Boyer LV, Theodorou AA, Berg RA, Mallie J, Arizona Envenomation Investigators, Chávez-Méndez A, García-Ubbelohde W, Hardiman S, Alagón A.
    N Engl J Med; 2009 May 14; 360(20):2090-8. PubMed ID: 19439743
    [Abstract] [Full Text] [Related]

  • 20. Neutralization of Latrodectus mactans and L. hesperus venom by redback spider (L. hasseltii) antivenom.
    Daly FF, Hill RE, Bogdan GM, Dart RC.
    J Toxicol Clin Toxicol; 2001 May 14; 39(2):119-23. PubMed ID: 11407496
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.